Neurological Institute Outcomes
Surgical Quality Improvement
January 1, 2021 – December 31, 2021
The American College of Surgeons National Surgical Quality Improvement Program (ACS NSQIP®) objectively measures and reports risk-adjusted surgical outcomes based on a defined sampling and abstraction methodology. These outcomes data reflect Cleveland Clinic’s overall neurosurgery ACS NSQIP performance benchmarked against 357 participating sites.
|Neurosurgery (357 Sites)||N||Observed||Expected|
|30 Day Mortality||272||2.21%||2.21%|
|30 Day Morbidity||272||10.66%||9.63%|
|Ventilator > 48 Hours||272||1.47%||1.77%|
|Deep Vein Thrombosis (DVT) / Pulmonary Embolusᵃ||272||6.25%||3.30%|
|Urinary Tract Infection (UTI)||272||0.37%||1.76%|
|Surgical Site Infection (SSI)||272||2.57%||2.26%|
|Return to Operating Room (ROR)||272||4.41%||5.17%|
American College of Surgeons National Surgical Quality Improvement Program, 2022.
ACS NSQIP® Semiannual Report July 12, 2022, Chicago: American College of Surgeons.
ᵃIdentified as a statistical outlier (higher than expected) by the ACS NSQIP hierarchical model.